The Alkaloid Caulerpin Exhibits Potent and Selective Anti-Inflammatory Activity Through Interaction with the Glucocorticoid Receptor
Authors:
- Jônatas Sousa Pires dos SantosJSJônatas Sousa Pires dos Santos
- Dahara Keyse Carvalho SilvaDSDahara Keyse Carvalho Silva
- Vanessa da Silva OliveiraVOVanessa da Silva Oliveira
- Sergio Santos Silva JuniorSJSergio Santos Silva Junior
- Edivaldo dos Santos RodriguesEREdivaldo dos Santos Rodrigues
- Claudia Valeria Campos de SouzaCSClaudia Valeria Campos de Souza
- Sabrina Teixeira MartinezSMSabrina Teixeira Martinez
- Osvaldo Andrade Santos-FilhoOsvaldo Andrade Santos-Filho
- Cássio Santana MeiraCMCássio Santana Meira
- Milena Botelho Pereira SoaresMSMilena Botelho Pereira Soares
Open Access
- 29 May 2025
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 23 (6) , 232
Abstract
Inflammation plays a central role in various pathological conditions, necessitating the search for safer and more effective anti-inflammatory agents. This study investigates the anti-inflammatory activity of caulerpin, a bisindolic alkaloid isolated from Caulerpa racemosa. In vitro assays demonstrated that caulerpin significantly reduced nitric oxide, TNF-α, IL-6, and IL-12 levels in macrophages stimulated with LPS + IFN-γ, without affecting cell viability. In silico toxicity predictions using Protox 3.0 reinforce a favorable safety profile of caulerpin. Molecular docking and molecular dynamics simulations revealed its high-affinity binding to the glucocorticoid receptor ligand-binding domain (GR-LBD), suggesting a mechanism of action similar to dexamethasone. The involvement of the glucocorticoid receptor was confirmed by the partial reversal of caulerpin’s effects upon RU486 treatment. In vivo, caulerpin exhibited a favorable safety profile, with no signs of acute toxicity at an oral dose of 100 mg/kg. Moreover, in a mouse model of endotoxic shock, caulerpin administration significantly improved survival rates in a dose-dependent manner, providing complete protection at 4 mg/kg. These findings highlight caulerpin as a promising candidate for the development of novel anti-inflammatory therapies. Further studies are warranted to explore its pharmacokinetics, optimize its structure, and evaluate its efficacy in chronic inflammatory diseases.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado da Bahia (PPP0027/2024, 001)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (PPP0027/2024, 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (PPP0027/2024, 001)
This publication has 49 references indexed in Scilit:
- Software update: The ORCA program system—Version 5.0WIREs Computational Molecular Science, 2022
- Marine macroalga Caulerpa: role of its metabolites in modulating cancer signalingMolecular Biology Reports, 2019
- The role of human cytochrome P450 2E1 in liver inflammation and fibrosisHepatology Communications, 2017
- Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral InflammationCellular and Molecular Neurobiology, 2017
- Caulerpa consumption, nutritional value and farming in the Indo-Pacific regionJournal of Applied Phycology, 2016
- Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric PatientsClinical Pharmacokinetics, 2013
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- Peptide Folding: When Simulation Meets ExperimentAngewandte Chemie International Edition, 1999
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsAnalytical Biochemistry, 1982